Target intelligence / Profile preview

NACA pseudogene 2 (NACAP2)

Target
NACAP2
Molecular classification
Other (Processed pseudogene)
01

Overview

NACA pseudogene 2 is a **processed pseudogene** in humans, designated by the HGNC symbol NACAP2. It is a retrocopy of the ancestral *nascent polypeptide associated complex alpha subunit* (NACA) and is located on chromosome 10q26.12[4][10]. As a pseudogene, NACAP2 does not encode a functional protein and has no recognized biological or clinical function. Its sequence shares homology with the parent NACA gene, which is involved in protein folding, ribosome interaction, and transcriptional regulation, but NACAP2 itself is genetically inert and is not considered a therapeutic target, receptor, enzyme, or transporter[6][7][10]. There are no disease associations, interacting drugs, or mechanisms of action described for NACAP2. It is often included in genomic annotations due to its similarity to NACA, but its lack of protein coding potential makes it irrelevant for drug discovery or therapeutic intervention[7][10].

Other names
nascent polypeptide associated complex alpha subunit pseudogene 2nascent polypeptide-associated complex alpha subunit pseudogenenascent-polypeptide-associated complex alpha polypeptide pseudogene 2NACAP2
02

Mechanism of action

Not an actionable target

03

Biological functions

No known biological function; does not encode a functional protein
04

Disease associations

No direct disease association for the pseudogene itself
05

Safety considerations

No therapeutic or safety context
06

Interacting drugs

No interacting drugs; does not produce targetable protein
07

Biomarkers

Not used as a biomarker

Beyond the preview

Go deeper on NACA pseudogene 2 (NACAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NACA pseudogene 2 (NACAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call